期刊文献+

半乳糖凝集素3在COPD和肺癌中的表达及其意义 被引量:5

The Expression and Significance of Galectin-3 in COPD and Lung Cancer
下载PDF
导出
摘要 目的探讨半乳糖凝集素3(galectin-3,Gal-3)在慢性阻塞性肺疾病(chronic obstructive pulmonary diseases,COPD)和肺癌(Lung carcinoma)中的表达及其意义.方法 60只雌性SD大鼠随机分为3组:COPD组、肺癌组、空白对照组,每组20只大鼠.COPD组给予气道内注入脂多糖、香烟熏染制备模型.肺癌组给予3,4-苯并芘-玉米油混合溶液肺内注射制备模型.空白对照组正常饲养.观察20周后,用酶联免疫吸附法(ELISA)测定各组大鼠血浆半乳糖凝集素3(Gal-3)浓度.结果 COPD组、肺癌组、空白对照组半乳糖凝集素3平均浓度分别为(8.53±0.46)ng/m L、(9.15±0.69)ng/m L、(4.47±0.51)ng/m L.COPD组、肺癌组平均浓度均高于空白对照组,差异有统计学意义(P<0.05).结论半乳糖凝集素3对COPD和肺癌均出现过表达,说明其可能对COPD和肺癌的发生、发展及预后有重要意义. Objective To explore the expression and significance of galectin-3 in COPD and lung cancer.Methods Sixty female SD rats were randomly divided into three groups: COPD group,lung cancer group and the control group with 20 rats in each group. COPD group was given tracheal injection of lipopolysaccharide and exposed to daily cigarette to establish the model. Lung cancer group was injected with 3, 4-benzopyrene-corn mixture. The control group was fed normally. After 20 weeks, plasma galectin-3 concentration was assessed in each group using ELISA method. Results The galectin-3 average concentrations of COPD group,lung cancer group and the control group were(8.63 ±0.46) ng/m L,(9.15±0.69) ng/m L and(4.47±0.51) ng/m L. The average concentrations in COPD and lung cancer groups were higher than that of the control group with a statistically significant difference(P〈0.05). Conclusion As expressed in COPD and lung cancer, galectin-3may own a great significance to the occurrence, development and prognosis of COPD and lung cancer.
作者 赵杰 杨立民 张震 王洪 ZHAO Jie YANG Li-min ZHANG Zhen WANG Hong(The Dept. of Thoracic and Cardiovascular Surgery, The 2nd Affiliated Hospital of Kunming Medical University, Kunming Yunnan 650101, China)
出处 《昆明医科大学学报》 CAS 2016年第8期51-54,共4页 Journal of Kunming Medical University
基金 云南省卫生科技计划项目(2012WS0104)
关键词 半乳糖凝集素3 COPD 肺癌 Galactose lectin 3 COPD Lung cancer
  • 相关文献

参考文献5

二级参考文献40

  • 1张永,程德云,王慧,苏巧俐,陈小菊,关键.慢性阻塞性肺疾病大鼠肺内白细胞介素-8和肿瘤坏死因子-α与气道炎症的关系研究[J].中国呼吸与危重监护杂志,2003,2(6):355-359. 被引量:41
  • 2慢性阻塞性肺疾病诊治指南(2007年修订版)[J].中华内科杂志,2007,46(3):254-261. 被引量:1794
  • 3[1]Tesfaigzi Y,Wright PS,Belinsky SA.SPRR1B overexpression enhances entry of cells into the GO phase of the cell cycle.Am J Physiol Lung Cell Mol Physiol,2003,285(4):L889-L898.
  • 4[2]Mauderly JL,Gigliotti AP,Barr EB,et al.Chronic inhalation exposure to mainstream cigarette smoke increases lung and nasal tumor incidence in rats.Toxicol Sci,2004,81(2):280-292.
  • 5[3]Panwar M,Samarth R,Kumar M,et al.Inhibition of benzo(a)pyrene induced lung adenoma by panax ginseng extract,EFLA400,in Swiss albino mice.Biol Pharm Bull,2005,28(11):2063-2067.
  • 6[4]Gunning WT,Kramer PM,Lubet RA,et al.Chemoprevention of benzo(a)pyrene-induced lung tumors in mice by the farnesyltransferase inhibitor R115777.Clin Cancer Res,2003,9 (5):19271930.
  • 7[5]Wislocki PG,Bagan ES,Lu AY,et al.Tumorigenicity of nitrated derivatives of pyrene,benz[a] anthracene,chrysene and benzo[a]pyrene in the newborn mouse assay.Carcinogenesis,1986,7(8):1317-1322.
  • 8[7]Yun TK,Kim SH,Lee YS.Trial of a new medium-term model using benzo(a) pyrene induced lung tumor in newborn mice.Anti cancer Res,1995,15(3):839-845.
  • 9[8]Hecht SS,Isaacs S,Trushin N.Lung tumor induction in A/J mice by the tobacco smoke carcinogens 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and benzo[a] pyrene:a potentially useful model for evaluation of chemopreventive agents.Carcinogenesis,1994,15(12):2721-2725.
  • 10[10]Iwagawa M,Maeda T,Izumi K,et al.Comparative dose-response study on the pulmonary carcinogenicity of 1,6-dinitropyrene and benzo[a] pyrene in F344 rats.Carcinogenesis,1989,10(7):1285-1290.

共引文献46

同被引文献47

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部